Gastrointestinal mucosal abnormalities using videocapsule endoscopy in systemic sclerosis

Alimentary Pharmacology and Therapeutics

Volumn 40, Issue 2, 2014, Pages 189-199

  Marie, I ^a   Antonietti, M ^a   Houivet, E ^a   Hachulla, E ^b   Maunoury, V ^b   Bienvenu, B ^c   Viennot, S ^c   Smail, A ^d   Duhaut, P ^d   Dupas, J L ^d   Dominique, S ^a   Hatron, P Y ^b   Levesque, H ^a   Benichou, J ^a   Ducrotte P ^a  

^a ROUEN UNIVERSITY HOSPITAL   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

^c CAEN UNIVERSITY HOSPITAL   (France)

^d AMIENS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CENTROMERE ANTIBODY; FERRITIN;

ADULT; AGED; ANEMIA; ANGIODYSPLASIA; ARTICLE; CONTROLLED STUDY; FEMALE; FINGER ULCER; GASTROINTESTINAL DISEASE; GASTROINTESTINAL HEMORRHAGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUCOSAL DISEASE; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SMALL INTESTINE DISEASE; STOMACH DISEASE; SYSTEMIC SCLEROSIS; TELANGIECTASIA; VIDEOCAPSULE ENDOSCOPY; VIDEOENDOSCOPY;

ADULT; AGED; CAPSULE ENDOSCOPY; COHORT STUDIES; FEMALE; FRANCE; GASTROINTESTINAL HEMORRHAGE; HUMANS; INTESTINAL MUCOSA; MALE; MIDDLE AGED; PREVALENCE; SCLERODERMA, SYSTEMIC;

EID: 84902883127     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.12818     Document Type: Article

References (50)

1. Forbes A, Marie I,. Gastrointestinal complications: the most frequent internal complications of systemic sclerosis. Rheumatology (Oxford) 2009; 48: iii36-9.
2. Marie I, Ducrotte P, Antonietti M, et al,. Watermelon stomach in systemic sclerosis: its incidence and management. Aliment Pharmacol Ther 2008; 28: 412-21.
3. Marie I, Dominique S, Levesque H, et al,. Esophageal involvement and pulmonary manifestations in systemic sclerosis. Arthritis Rheum 2001; 45: 346-54.
4. Marie I, Ducrotté P, Denis P, et al,. Oesophageal mucosal involvement in patients with systemic sclerosis receiving proton pump inhibitor therapy. Aliment Pharmacol Ther 2006; 24: 1593-601.
5. Marie I, Ducrotté P, Hellot MF, et al,. Outcome of small bowel motor impairment in systemic sclerosis: a prospective manometric 5-year follow-up. Rheumatology (Oxford) 2007; 46: 150-3.
6. Marie I, Gehanno JF, Bubenheim M, et al,. Prospective study to evaluate the association between systemic sclerosis and occupational exposure and review of the literature. Autoimmun Rev 2014; 13: 151-6.
7. Marie I, Gourcerol G, Leroi AM, et al,. Delayed gastric emptying determined using the 13C-octanoic acid breath test in patients with systemic sclerosis. Arthritis Rheum 2012; 64: 2346-55.
8. Marie I, Levesque H, Ducrotté P, et al,. Gastric involvement in systemic sclerosis: a prospective study. Am J Gastroenterol 2001; 41: 1874-83.
9. Marie I, Levesque H, Ducrotté P, et al,. Manometry of the upper intestinal tract in patients with systemic sclerosis: a prospective study. Arthritis Rheum 1998; 96: 77-83.
10. Poirier TJ, Rankin GB,. Gastrointestinal manifestations of progressive systemic scleroderma based on a review of 364 cases. Am J Gastroenterol 1972; 58: 30-44.
11. Gyger G, Baron M,. Gastrointestinal manifestations of scleroderma: recent progress in evaluation, pathogenesis, and management. Curr Rheumatol Rep 2012; 14: 22-9.
12. Ingraham KM, O'Brien MS, Shenin M, et al,. Gastric antral vascular ectasia in systemic sclerosis: demographics and disease predictors. J Rheumatol 2010; 37: 603-7.
13. Bluestone R, MacMahon M, Dawson JM,. Systemic sclerosis and small bowel involvement. Gut 1969; 10: 185-93.
14. D'Angelo WA, Fries JF, Masi AT, et al,. Pathologic observations in systemic sclerosis (scleroderma): a study of fifty-eight autopsy cases and fifty-eight matched controls. Am J Med 1969; 46: 428-40.
15. Heinz ER, Steinberg AJ, Sackner MA,. Roentgenographic and pathologic aspects on intestinal scleroderma. Ann Intern Med 1963; 59: 822-6.
16. Reinhardt JF, Barry WF,. Scleroderma of the small bowel. Am J Roentgenol 1962; 88: 687-92.
17. Tuffanelli DL, Winkelmann RK,. Systemic scleroderma. A clinical study of 727 cases. Arch Dermatol 1961; 84: 359-71.
18. Bailey AA, Debinski HS, Appleyard MN, et al,. Diagnosis and outcome of small bowel tumors found by capsule endoscopy: a three-center Australian experience. Am J Gastroenterol 2006; 101: 2337-43.
19. Ben Soussan E, Antonietti M, Hervé S, et al,. Diagnostic yield and therapeutic implications of capsule endoscopy in obscure gastrointestinal bleeding. Gastroenterol Clin Biol 2004; 28: 1068-73.
20. Carretero C, Fernandez-Urien I, Betes M, et al,. Role of videocapsule endoscopy for gastrointestinal bleeding. World J Gastroenterol 2008; 14: 5261-4.
21. Ciaccio EJ, Tennyson CA, Bhagat G, et al,. Implementation of a polling protocol for predicting celiac disease in videocapsule analysis. World J Gastrointest Endosc 2013; 5: 313-22.
22. Ersoy O, Sivri B, Arslan S, et al,. How much helpful is the capsule endoscopy for the diagnosis of small bowel lesions ? World J Gastroenterol 2006; 12: 3906-10.
23. Makins R, Blanshard C,. Guidelines for capsule endoscopy: diagnoses will be missed. Aliment Pharmacol Ther 2006; 24: 293-7.
24. Subcommittee for scleroderma Criteria of the American Rheumatism. Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581-90.
25. Leroy EC, Black C, Fleischmajer R, et al,. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988; 15: 202-5.
26. Johnson SR, Hawker GA, Davis AM,. The Health Assessment Questionnaire disability index and Scleroderma Health Assessment Questionnaire in scleroderma trials: an evaluation of their measurement properties. Arthritis Rheum 2005; 53: 256-62.
27. Cutolo M, Sulli A, Smith V,. Assessing microvascular changes in systemic sclerosis diagnosis and management. Nat Rev Rheumatol 2010; 6: 578-87.
28. Cutolo M, Pizzorni C, Tuccio M, et al,. Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis. Rheumatology (Oxford) 2004; 43: 719-26.
29. Sulli A, Secchi ME, Pizzorni C, et al,. Scoring the nailfold microvascular changes during the capillaroscopic analysis in systemic sclerosis patients. Ann Rheum Dis 2008; 67: 885-7.
30. Marie I, Ducrotté P, Denis P, et al,. Small intestinal bacterial overgrowth in systemic sclerosis. Rheumatology (Oxford) 2009; 48: 1314-9.
31. Lecleire S, Iwanicki-Caron I, Di-Fiore A, et al,. Yield and impact of emergency capsule enteroscopy in severe obscure-overt gastrointestinal bleeding. Endoscopy 2012; 44: 337-42.
32. Greenberger NJ, Dobbins WO 3rd, Ruppert RD, et al,. Intestinal atony in progressive systemic sclerosis (scleroderma). Am J Med 1968; 45: 301-8.
33. Nash AG, Fountain R,. Surgical presentation of systemic sclerosis of the small intestine. Br J Surg 1968; 55: 667-72.
34. Kitiyakara T, Selby W,. Non-small bowel lesions detected by capsule endoscopy in patients with obscure GI bleeding. Gastrointest Endosc 2005; 62: 234-8.
35. Ohira T, Hokama A, Kinjo N, et al,. Detection of active bleeding from gastric antral vascular ectasia by capsule endoscopy. World J Gastrointest Endosc 2013; 5: 138-40.
36. Sidhu R, Sanders DS, McAlindon ME,. Does capsule endoscopy recognise gastric antral vascular ectasia more frequently than conventional endoscopy? J Gastrointest Liver Dis 2006; 15: 375-7.
37. Tang SJ, Zanati S, Kandel G, et al,. Gastric intestinal vascular ectasia syndrome: findings on capsule endoscopy. Endoscopy 2005; 37: 1244-7.
38. Kaye SA, Seifalian AM, Lim SG, Hamilton G, Black CM,. Ischaemia of the small intestine in patients with systemic sclerosis: Raynaud's phenomenon or chronic vasculopathy? QJM 1994; 87: 495-500.
39. Piasecki C, Chin J, Greenslade L, McIntyre N, Burroughs AK, McCormick PA,. Endoscopic detection of ischaemia with a new probe indicates low oxygenation of gastric epithelium in portal hypertensive gastropathy. Gut 1995; 36: 654-6.
40. Ghrénassia E, Avouac J, Khanna D, et al,. Prevalence, Correlates and Outcomes of gastric antral vascular ectasia in systemic sclerosis: a EUSTAR Case-control Study. J Rheumatol 2014; 41: 99-105.
41. Hung EW, Mayes MD, Sharif R, et al,. Gastric antral vascular ectasia and its clinical correlates in patients with early diffuse systemic sclerosis in the SCOT trial. J Rheumatol 2013; 40: 455-60.
42. Ceribelli A, Cavazzana I, Airò P, et al,. Anti-RNA polymerase III antibodies as a risk marker for early gastric antral vascular ectasia (GAVE) in systemic sclerosis. J Rheumatol 2010; 37: 1544.
43. Sulli A, Pizzorni C, Smith V, et al,. Timing of transition between capillaroscopic patterns in systemic sclerosis. Arthritis Rheum 2012; 64: 821-5.
44. Sulli A, Ruaro B, Alessandri E, et al,. Correlations between nailfold microangiopathy severity, finger dermal thickness and fingertip blood perfusion in systemic sclerosis patients. Ann Rheum Dis 2014; 73: 247-51.
45. Forbess LJ, Gordon JK, Doobay K, et al,. Low prevalence of coeliac disease in patients with systemic sclerosis: a cross-sectional study of a registry cohort. Rheumatology (Oxford) 2013; 52: 939-43.
46. Luft LM, Barr SG, Martin LO, et al,. Autoantibodies to tissue transglutaminase in Sjogren's syndrome and related rheumatic diseases. J Rheumatol 2003; 30: 2613-9.
47. Rosato E, De Nitto D, Rossi C, et al,. High incidence of celiac disease in patients with systemic sclerosis. J Rheumatol 2009; 36: 965-9.
48. van Tilburg AJ, van Blankenstein M, Verschoor L,. Intestinal lymphangiectasia in systemic sclerosis. Am J Gastroenterol 1988; 83: 1418-9.
49. Onishi A, Sugiyama D, Kumagai S, et al,. Cancer incidence in systemic sclerosis: meta-analysis of population-based cohort studies. Arthritis Rheum 2013; 65: 1913-21.
50. Szekanecz E, Szamosi S, Horváth A, et al,. Malignancies associated with systemic sclerosis. Autoimmun Rev 2012; 11: 852-5.